Loading clinical trials...
Loading clinical trials...
Conditions
Interventions
3,4-Methylenedioxymethamphetamine (MDMA)
Placebo
+1 more
Locations
1
United States
Emory Brain Health Center
Atlanta, Georgia, United States
Start Date
April 1, 2026
Primary Completion Date
January 1, 2030
Completion Date
January 1, 2030
Last Updated
April 13, 2026
NCT07485231
NCT06947538
NCT07462312
NCT07351305
NCT06516874
NCT06740487
Lead Sponsor
Emory University
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions